Deep Track Capital, LP Sage Therapeutics, Inc. Transaction History

Deep Track Capital, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$27.52 - $37.99 $13.8 Million - $19.1 Million	-503,200 Reduced 74.55%	171,800 $5.55 Million
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $5.37 Million - $8 Million	175,000 Added 35.0%	675,000 $22.3 Million
Q4 2021 Feb 14, 2022	BUY	$37.06 - $47.11 $18.5 Million - $23.6 Million	500,000 New	500,000 $21.3 Million

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.